Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Bone Joint Surg Br ; 93(7): 886-9, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21705558

RESUMEN

The direct anterior approach in total hip replacement anatomically offers the chance to minimise soft-tissue trauma because an intermuscular and internervous plane is explored. This motivated us to abandon our previously used transgluteal approach and to adopt the direct anterior approach for total hip replacement. Using MRI, we performed a retrospective comparative study of the direct anterior approach with the transgluteal approach. There were 25 patients in each group. At one year post-operatively all the patients underwent MRI of their replaced hips. A radiologist graded the changes in the soft-tissue signals in the abductor muscles. The groups were similar in terms of age, gender, body mass index, complexity of the reconstruction and absence of symptoms. Detachment of the abductor insertion, partial tears and tendonitis of gluteus medius and minimus, the presence of peri-trochanteric bursal fluid and fatty atrophy of gluteus medius and minimus were significantly less pronounced and less frequent when the direct anterior approach was used. There was no significant difference in the findings regarding tensor fascia lata between the two approaches. We conclude that use of the direct anterior approach results in a better soft-tissue response as assessed by MRI after total hip replacement. However, the impact on outcome needs to be evaluated further.


Asunto(s)
Artroplastia de Reemplazo de Cadera/efectos adversos , Artroplastia de Reemplazo de Cadera/métodos , Músculo Esquelético/lesiones , Traumatismos de los Tendones/etiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos/efectos adversos , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Estudios Retrospectivos , Traumatismos de los Tendones/diagnóstico , Resultado del Tratamiento
2.
Z Orthop Ihre Grenzgeb ; 140(1): 72-6, 2002.
Artículo en Alemán | MEDLINE | ID: mdl-11898068

RESUMEN

AIM: The aim of this study is to prove the intra- and interobserver reliability of three different methods to measure the active range-of-motion in the forearm. METHODS: These three different methods were tested on forty volunteers. In the first method pictures were made in full supination and pronation, measurement of the two angles was performed with a dedicated software. Active range-of-motion was defined as the magnitude of forearm rotation between maximum pronation and supination. The second method used a standard goniometer. The third method of assessment used a gravity goniometer (plurimeter). We randomised both the side of the patient to be examined and the sequence of the methods. Two examiners measured subsequently the range-of-motion twice with these three devices. RESULTS: We found a significant intraobserver reproducibility with the gravity goniometer. There was no significance with the goniometer or pictures. The intraobserver reproducibility of the latter two methods was poor. The interobserver reproducibility of the gravity goniometer and pictures was significant, for the goniometer it was poor. Agreement between the pictures and gravity goniometer assessment of the range-of-motion was good. None of these two methods was significantly correlated with the goniometer assessment. CONCLUSION: For reproducibility of measurement of range-of-motion in the forearm the gravity goniometer is the best method, although the measured values were 5 % greater.


Asunto(s)
Articulación del Codo/fisiología , Antebrazo/fisiología , Rango del Movimiento Articular/fisiología , Articulación de la Muñeca/fisiología , Adulto , Diagnóstico por Computador/instrumentación , Femenino , Humanos , Masculino , Variaciones Dependientes del Observador , Pronación/fisiología , Reproducibilidad de los Resultados , Programas Informáticos , Supinación/fisiología
3.
Anesthesiology ; 95(4): 875-80, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11605927

RESUMEN

BACKGROUND: The incidence, etiology, and evolution of complications after interscalene brachial plexus block (ISB) are not well-known. The authors prospectively monitored 521 patients for complications during the first 9 months after ISB. METHODS: A total of 521 adults scheduled for elective shoulder surgery performed with an ISB were included in this prospective study. The ISB procedure was standardized for all patients Acute complications were recorded. Patients were observed daily (for 10 days) for paresthesias, dysesthesias, pain not related to surgery, and muscular weakness and were evaluated at 1, 3, 6, and 9 months after surgery. Persistence of paresthesias dysesthesias, pain not related to surgery, or muscular weakness was investigated at 1 or 3 months by means of electroneuromyography. Final evaluation was performed at 9 months. RESULTS: A total of 520 patients completed the study; one was excluded after surgical axillary nerve damage. Two hundred thirty-four patients had an interscalene catheter. Acute complications consisted of one pneumothorax (0.2%) and one episode of central nervous system toxicity (incoherent speech; 0.2%). A 10 days, 74 patients (14%) were symptomatic, and none had muscular weakness. At 1 month, 41 patients (7.9%) had symptoms, and none had muscular weakness. Thirty patients under went electroneuromyography; sulcus ulnaris syndrome (n = 8) carpal tunnel syndrome (n = 2), and complex regional pain syndrome (n = 1) were diagnosed. At 3 months 20 patient (3.9%) were symptomatic, and none had muscular weakness All underwent electroneuromyography; carpal tunnel syndrome (n = 2), complex regional pain syndrome (n = 4), plexus neuropathy (n = 1), and plexus damage (n = 1) were diagnosed. At 6 months, 5 patients (0.9%) were symptomatic. At 9 months 1 patient (0.2%) had persistence of dysesthesia. CONCLUSIONS: Interscalene brachial plexus block performed with a standardized technical approach, material, and drugs is associated with an incidence of short- and severe long-term complications of 0.4%. In case of persistent paresthesia, dysesthesia, or pain not related to surgery after ISB, sulcus ulnaris syndrome, carpal tunnel syndrome, or complex regional pain syndrome should be excluded since specific treatment may be required.


Asunto(s)
Bloqueo Nervioso/efectos adversos , Procedimientos Ortopédicos/efectos adversos , Complicaciones Posoperatorias/epidemiología , Hombro/cirugía , Adolescente , Adulto , Anciano , Plexo Braquial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor Postoperatorio/diagnóstico por imagen , Dolor Postoperatorio/etiología , Parestesia/epidemiología , Parestesia/etiología , Estudios Prospectivos , Hombro/diagnóstico por imagen , Factores de Tiempo , Ultrasonografía
4.
Anesth Analg ; 92(1): 218-23, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11133631

RESUMEN

UNLABELLED: We compared the effects of patient-controlled interscalene analgesia with ropivacaine 0.2% and patient-controlled interscalene analgesia (PCIA) with bupivacaine 0.15% on hand grip strength after major open shoulder surgery. Sixty patients scheduled for elective major shoulder surgery were prospectively randomized to receive in a double-blinded fashion either ropivacaine or bupivacaine through an interscalene catheter. Before surgery, all patients received an interscalene block (ISB) with either 40 mL of 0.6% ropivacaine or 40 mL of 0.5% bupivacaine. Six h after ISB, the patients received a continuous infusion of either 0.2% ropivacaine or 0.15% bupivacaine for 48 h. In both groups, the PCIA infusion rate was 5 mL/h plus a bolus of 4 mL with a lockout time of 20 min. Strength in the hand was assessed preoperatively, 24 h, and 48 h after ISB and 6 h after stopping the infusion of local anesthetic. The presence of paresthesia in the fingers was checked. Pain relief was assessed using a visual analog scale; side effects were noted, and the patients rated their satisfaction 54 h after the block. A significant decrease of strength in the hand was observed in the Bupivacaine group 24, 48, and 54 h after ISB (P < 0.05). Paresthesia was more frequently reported in the Bupivacaine group for the second and third fingers 48 h after ISB (P < 0.05) and in the first three fingers 6 h after discontinuation of the local anesthetic infusion (P: < 0.05). The pain score was similar in the two groups at all times, and patient satisfaction was comparable between the two groups. We conclude that the use of the PCIA technique with ropivacaine 0.2% or bupivacaine 0.15% provides a similar pain relief after major shoulder surgery. However, ropivacaine 0.2% is associated with better preservation of strength in the hand and less paresthesia in the fingers. IMPLICATIONS: We compared the patient-controlled interscalene analgesia technique with ropivacaine 0.2% and bupivacaine 0.15% after major open shoulder surgery. For similar pain control ropivacaine is associated with better preservation of strength in the hand and less paresthesia in the fingers.


Asunto(s)
Amidas/administración & dosificación , Analgesia Controlada por el Paciente/métodos , Anestésicos Locales/administración & dosificación , Bupivacaína/administración & dosificación , Fuerza de la Mano/fisiología , Articulación del Hombro/cirugía , Adolescente , Adulto , Anciano , Amidas/efectos adversos , Analgesia Controlada por el Paciente/efectos adversos , Anestésicos Locales/efectos adversos , Bupivacaína/efectos adversos , Cateterismo/métodos , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Destreza Motora/efectos de los fármacos , Bloqueo Nervioso/métodos , Dimensión del Dolor/efectos de los fármacos , Dolor Postoperatorio/tratamiento farmacológico , Náusea y Vómito Posoperatorios/inducido químicamente , Estudios Prospectivos , Ropivacaína
5.
Spine (Phila Pa 1976) ; 26(2): E1, 2001 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-11154544

RESUMEN

STUDY DESIGN: Description of a novel less invasive technique and prospective evaluation of associated morbidity and potential complications. OBJECTIVE: To investigate the feasibility of a novel endoscope-assisted retroperitoneal approach (REAM) for anterior lumbar interbody fusion (ALIF). SUMMARY OF BACKGROUND DATA: Minimally and less invasive approaches are currently favored to perform ALIF. However, the present endoscopic techniques have not found widespread acceptance, because they are technically demanding, and microsurgical techniques are not time effective when two separate approaches are needed for L5-S1 (transperitoneal) and L4-L5 (retroperitoneal). METHODS: The authors have developed the technique of REAM, which consists of three stages: 1) endoscopic retroperitoneal mobilization of the peritoneal sac, 2) midline minilaparotomy (4-6 cm), and 3) standard open anterior lumbar interbody fusion. Twenty patients were prospectively enrolled in this study and perioperative data (i.e., blood loss, operative time, intra- and postoperative complications) were collected to assess the feasibility of this approach. RESULTS: Six single-level and 14 two-level ALIFs from L3-L4 to L5-S1 were performed with a mean operative time of 108 minutes (range, 85-150) and an average estimated blood loss of 200 mL (range, 50-500). The follow-up (range, 12-29 months) on 20 patients showed that there were no perioperative or postoperative complications related directly to this approach. CONCLUSION: Anterior lumbar interbody fusion by REAM can be performed without additional hazard to the patient and appears to be a reasonable alternative to existing less invasive procedures.


Asunto(s)
Endoscopía/métodos , Laparotomía/métodos , Vértebras Lumbares/cirugía , Complicaciones Posoperatorias/etiología , Espacio Retroperitoneal/cirugía , Fusión Vertebral/métodos , Endoscopía/efectos adversos , Humanos , Laparotomía/efectos adversos , Vértebras Lumbares/patología , Complicaciones Posoperatorias/prevención & control , Estudios Prospectivos , Fusión Vertebral/efectos adversos
6.
Surg Gynecol Obstet ; 141(4): 555-61, 1975 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1166380

RESUMEN

Dry heat forms a specific burn toxin in mouse and human skin from a naturally occurring precursor by a polymerization process and not by producing breakdown products. Precursor and toxin are both macromolecular lipid-protein complexes with similar chemical composition and physical structure both occurring in mouse and human skin as well as in serum of burned patients. Specific toxicity resides only in the apoprotein of the polymeric toxic form which also has new specific artificially produced antigenic site or sites. This phenomenon makes it possible to jump the species from man to mouse, shown by the success of specific immunotherapy. Neutral apolar lipids of the coat are contributing in an unspecific but significant manner to the toxic effect. Bacteria are not involved in toxin production nor in toxin activity. The target systems of the toxin are the cell wall membranes of all parenchymal cells of paractically all organs. The toxin apparently causes severe damage of the membrane verified by an increased permeability for compounds which otherwise do not penetrate. This basic cell damage itself is able to kill the animal, depending on the ratio of intact to damaged cells. Sublethal doses of toxin, however, prepare the background upon which bacteremia in burn injuries leads to a lethal sepsis. Finally, the direct toxic action as well as the enhancement of the susceptibility for gram-negative organisms both leading to the lethal outcome can be counteracted by specific passive antitoxic immunotherapy.


Asunto(s)
Quemaduras/inmunología , Infecciones por Pseudomonas/prevención & control , Toxinas Biológicas , Infección de Heridas/inmunología , Animales , Antitoxinas/uso terapéutico , Quemaduras/complicaciones , Quemaduras/metabolismo , Radioisótopos de Carbono , Humanos , Inmunoglobulina G/administración & dosificación , Ratones , Infecciones por Pseudomonas/inmunología , Conejos , Piel/análisis , Toxinas Biológicas/aislamiento & purificación
7.
Eur J Clin Pharmacol ; 8(5): 371-6, 1975 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-1243983

RESUMEN

Various brands of digoxin tablets, and even different batches of one brand, may differ greatly in bioavailability. Digoxin-Sandoz tablets have been compared with Lanoxin manufactured between 1969 and 1972 and after May 1972. Comparisons were also made between and within batches of Digoxin-Sandoz tablets. Three separate cross-over studies were conducted involving a total of 20 volunteers. Digoxin-Sandoz tablets were shown to have a constant bioavailability and to produce plasma concentrations very similar to ""new'' Lanoxin. Storage for 2 years of one batch of Digoxin-Sandoz did not alter the bioavailability. Particle size was shown to influence bioavailability. Care should be exercised when plasma data alone are interpreted as an index of bioavailability. Measures of bioavailability based on plasma data obtained up to 6 h after administration differed from those based on cumulative urinary excretion data (in this study by a factor of about 2), which can lead to the belief that a difference in bioavailability is much greater than is actually the case. Data from cumulative urinary excretion, collected over a sufficiently long period of time, are likely to be the most reliable method for determining the bioavailability of a substance such as digoxin.


Asunto(s)
Digoxina/metabolismo , Adulto , Disponibilidad Biológica , Cápsulas , Digoxina/administración & dosificación , Humanos , Cinética , Masculino , Persona de Mediana Edad , Tamaño de la Partícula , Comprimidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA